BIOMARKER:

RB1 deletion

Entrez ID:

Related biomarkers:

‹

›

RB1 deletion RB1 deletion	Prostate Cancer Prostate Cancer	RB1 deletion RB1 deletion	Prostate Cancer Prostate Cancer	abiraterone acetate Resistant: B - Late Trials	abiraterone acetate Resistant: B - Late Trials
RB1 deletion RB1 deletion	Prostate Cancer Prostate Cancer	RB1 deletion RB1 deletion	Prostate Cancer Prostate Cancer	enzalutamide capsule Resistant: B - Late Trials	enzalutamide capsule Resistant: B - Late Trials
RB1 deletion RB1 deletion	Hormone Receptor Positive Breast Cancer Hormone Receptor Positive Breast Cancer	RB1 deletion RB1 deletion	Hormone Receptor Positive Breast Cancer Hormone Receptor Positive Breast Cancer	palbociclib Resistant: C3 – Early Trials	palbociclib Resistant: C3 – Early Trials
RB1 deletion RB1 deletion	Melanoma Melanoma	RB1 deletion RB1 deletion	Melanoma Melanoma	palbociclib Resistant: D – Preclinical	palbociclib Resistant: D – Preclinical
RB1 deletion RB1 deletion	Mesothelioma Mesothelioma	RB1 deletion RB1 deletion	Mesothelioma Mesothelioma	BI 6727 Sensitive: D – Preclinical	BI 6727 Sensitive: D – Preclinical
RB1 deletion RB1 deletion	Mesothelioma Mesothelioma	RB1 deletion RB1 deletion	Mesothelioma Mesothelioma	MLN8237 Sensitive: D – Preclinical	MLN8237 Sensitive: D – Preclinical
RB1 deletion RB1 deletion	Mantle Cell Lymphoma Mantle Cell Lymphoma	RB1 deletion RB1 deletion	Mantle Cell Lymphoma Mantle Cell Lymphoma	palbociclib Sensitive: D – Preclinical	palbociclib Sensitive: D – Preclinical
RB1 deletion RB1 deletion	Ovarian Cancer Ovarian Cancer	RB1 deletion RB1 deletion	Ovarian Cancer Ovarian Cancer	SRA515 Sensitive: D – Preclinical	SRA515 Sensitive: D – Preclinical
RB1 deletion RB1 deletion	Ovarian Cancer Ovarian Cancer	RB1 deletion RB1 deletion	Ovarian Cancer Ovarian Cancer	palbociclib + SRA515 Sensitive: D – Preclinical	palbociclib + SRA515 Sensitive: D – Preclinical